Adaptability of an Undetectable = Untransmissible Model for HBV
Recruiting now
Conditions studied: Chronic Hepatitis b, Viremia
In brief
Persons with chronic hepatitis B (HBV) infection and active viremia are infectious and may transmit virus to others through blood/body fluid exposure. Immune tolerant treatment naive persons with hepatitis B infection express anxiety regarding disclosure of their infection status and significant fear of transmission to their partners leading to social isolation and impact on their personal lives. This study will provide data correlating serum and body fluid viral levels in persons with chronic hepatitis B infection not on therapy and those with viral suppression on long-term anti-retroviral therapy (ART) that may support the concept of "Undetectable=Untransmissible" (U=U) in patients with chronic hepatitis B.
Key facts
- Study ID
- NCT07449091
- Run by
- NYU Langone Health
- People needed
- 55
- Starts
- 2026-05-01
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2026-05-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Infected Individuals
- Individuals above 18 years and less than 65 years with chronic hepatitis B infection
- Included according to undermentioned three arms:
- Infected, On-treatment arm: subjects being treated with TAF/TDF for a minimum of 2 years with sustained viral suppression indicating adherence to therapy
- Infected, Untreated control arm: Immune tolerant subjects; 15 with high viral load (>10\^6) and 5 with low viral load (<10\^6)
- Uninfected Assay Validation controls: 10 subjects with history of prior infection who have convalesced i.e., have lost surface antigen, and developed surface antibody with viral eradication
- Able and willing to provide informed consent
- Healthy Controls
- Individuals above 18 years and less than 65 years who have never been infected and have been vaccinated
- Able and willing to provide informed consent
You may not qualify if…
- Individuals less than 18 years or greater than 65 years of age
- Prior surgery to genitourinary tract, including prior vasectomy
- Prior interferon therapy
- HIV co-infection
- Hepatitis C virus co-infection
- Hepatitis delta virus co-infection
Where it is running
- NYU Langone Health — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.